Opinions in Healthcare

Onyda XR

On May 24, 2024, the FDA approved Onyda XR (clonidine hydrochloride), a liquid non-stimulant medication for attention deficit hyperactivity disorder (ADHD). Developed by Tris Pharma, Onyda XR is a centrally acting alpha 2

Read More

Wegovy Shortage

In recent months, there has been a surge in clinicians prescribing subcutaneous injections for weight loss to their patients. As a result, manufacturers have struggled to keep up with the increased demand. Pharmacies

Read More

Opill

On July 13, 2023, the FDA approved the first over-the-counter birth control called ‘Opill’. An increased availability of hormonal birth control without a prescription may increase access and remove the barriers that individuals

Read More

Beyfortus

On July 18th, 2023, the FDA approved Beyfortus (nirsevimab-alip) for the prevention of Respiratory Syncytial Virus (RSV) in neonates and infants born during or entering their first RSV season, and in children up

Read More

The Explosion of Telehealth in Healthcare

Due to COVID-19 and the practice of social distancing, the surge of telehealth/telemedicine increased more than what was expected. Federal and state telehealth policy changes were to help accommodate as many people as

Read More

Anti-Aging for Men

Anti-aging is something that is sought after by many people. In the past, many anti-aging treatments have been created and marketed for women, however, there is now a growing market for anti-aging treatments

Read More